Abilify for Schizophrenia

Links shared publicly online about this topic

Quebec agrees reimbursement of ABILIFY for schizophrenia treatment in public drug plans

news-medical.net — “Bristol-Myers Squibb Canada is pleased to announce that Quebec has recognized the value of ABILIFY (aripiprazole) for the treatment of schizophrenia and related psychotic disorders in adults and has agreed to list ABILIFY as a reimbursed full benefit on the Quebec public drug plans as of October 14, 2010.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 27, 2010 at 8:46 am By:

NewsMedical News-Medical.Net Health News

Quebec agrees reimbursement of ABILIFY for schizophrenia treatment in public drug plans: Bristol-Myers Squibb Cana... http://bit.ly/bY3JVo

2 years ago...

Treat Schizophrenia and Bipolar Disorder With Abilify

health.ezinemark.com — “Typically Abilify is a medication that you can avail of only with a doctor's prescription to treat diseases like schizophrenia and bipolar disorder and in recent years it has also been found effective to treat the irritation that arises in autistic patients. It is also used in the treatment of major depression in combination w8ith an antidepressant medication and this is termed augmentation.View full resource at health.ezinemark.com

  • View Related
  • Share

Most Recently Shared on September 21, 2010 at 1:59 pm By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Treat Schizophrenia and Bipolar Disorder With Abilify http://bit.ly/dD3SW5 #bipolar

2 years ago...

The latest medication to treat schizophrenia "ABILIFY" launched in Canada

news-medical.net — “A new treatment option for Canadians with schizophrenia, ABILIFY(TM) (aripiprazole), is now available in Canada. For those living with this lifelong disease who may be struggling with a treatment that doesn't work for them or with side effects that are difficult to tolerate, ABILIFY offers efficacy and good safety and tolerability with limited impact on weight, blood sugar and lipids - significant clinical benefits that may help patients stay on treatment longer.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 6, 2009 at 7:11 pm By:

HIVAIDS_News News-Medical.Net Health News

HIV/AIDS News: The latest medication to treat schizophrenia "ABILIFY" launched in Canada: A new t.. http://bit.ly/189U0t

3 years ago...

NICE wants more data on BMS schizophrenia drug Abilify for teens | Reuters - Jack's posterous

pharmagossip.posterous.com — “NICE wants more data on BMS schizophrenia drug Abilify for teens | Reuters - Jack's posterousView full resource at pharmagossip.posterous.com

  • View Related
  • Share

Most Recently Shared on September 10, 2010 at 5:48 am By:

pharmagossip Jack Friday - PharmaGossip Health Blog

NICE wants more data on BMS schizophrenia drug Abilify for teens | Reuters http://post.ly/wfOV

2 years ago...

RxEconsult, LLC - Abilify (aripiprazole) for schizophrenia, bipolar disorder, depression, and autistic disorder

rxeconsult.com — “RxEconsult, LLC - Abilify (aripiprazole) for schizophrenia, bipolar disorder, depression, and autistic disorderView full resource at rxeconsult.com

  • View Related
  • Share

Most Recently Shared on October 25, 2011 at 2:25 am By:

RxEconsultRxEconsult. If you are in need of healthcare services or information, please visit RxEconsult. 

Dr. Ogbru received his Doctorate in Pharmacy from the University of the Pacific School of Pharmacy in 1995. He completed a Pharmacy Practice Residency at the University of Arizona/University Medical Center in 1996. He was a Professor of Pharmacy Practice and a Regional Clerkship Coordinator for the University of the Pacific School of Pharmacy from 1996-99.

Dr. Ogbru has written several journal articles. In 1997, he shared an award from the American Journal of Pain Management for Outstanding Contribution to the Interdisciplinary Pain Management Literature. Over the last 12 years Dr. Ogbru has held several roles in the pharmaceutical industry, including Director of Global Medical Information and Communication." /> Ome Ogbru, PharmD Active Health Library, Doctor, Pharmacist, and PharmD

#Abilify (aripiprazole) for #schizophrenia, #bipolar disorder, #depression, and #autistic disorder http://t.co/Q4HZwIpq #health #Medications

7 months ago...

Google Sidewiki entry about Add-on Depression Treatment| Bipolar Mania and Schizophrenia | ABILIFY® (aripiprazole)

google.com — “Abilify was the #1 DTC advertiser in Q1 2009, spending $61.9 million that quarter vs. $24.5 million in Q1 2008. Why the big increase? Was it to offset the bad press reported in the following Pharma Marketing Blog posts? Andy Behrman, Now an Anti-BMS Spokesperson, Says "Ask Your Doctor If Abilify is Wrong for You" See: http://bit.ly/JgBRO Behrman Wasn't the FirsView full resource at google.com

  • View Related
  • Share

Most Recently Shared on October 5, 2009 at 12:54 pm By:

pharmaguy John Mack Health Executive

Just wrote a Sidewiki entry on Abilify.com http://bit.ly/10tuf0 Why the big increase in DTC spending Q1 2009 v Q1 2008? I think I know ...

3 years ago...

ABILIFY® (aripiprazole) | Add-on Depression | Bipolar Disorder | Schizophrenia

abilify.com — “Learn how prescription ABILIFY can help as an add-on depression treatment, or treatment for Bipolar Disorder (Manic or Mixed) or Schizophrenia in adults.View full resource at abilify.com

  • View Related
  • Share

Most Recently Shared on December 22, 2011 at 2:19 pm By:

News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health

reuters.com — “News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #healthView full resource at reuters.com

  • View Related
  • Share

Most Recently Shared on September 10, 2010 at 3:45 am By:

hrana Hisham Rana, MD Doctor and Physician

News: UK's NICE wants more data on the effectiveness of Bristol-Myers Squibb's schizophrenia drug Abilify http://bit.ly/9Zrcsf - #health

2 years ago...

Bristol Myers Squibb Gets Subpoena for Abilify Information - Businessweek

businessweek.com — “Bristol-Myers Squibb Co. said it received a subpoena from the U.S. attorney’s office in New York asking for information about sales and marketing of its second- best-selling drug, Abilify, used to treat schizophrenia and other mood disorders.View full resource at businessweek.com

  • View Related
  • Share

Most Recently Shared on February 21, 2012 at 6:18 pm By:

SidneyWolfeMD Sidney Wolfe, MD Doctor, Internist, and Physician

Bristol-Myers Squibb marketed LIMITED-USE drug #Abilify for non-approved use in kids and for dementia http://t.co/7ueqmUW0

3 months ago...

Bipolar-disorder Related Drugs, Abilify, Quetiapine - Drugs - EverydayHealth.com

everydayhealth.com — “Find information on prescription and OTC drugs that treat Bipolar-disorder like Abilify, Abilify Discmelt, Aripiprazole, Calan, Calan SR, Carbamazepine, Carbatrol, Catapres, Catapres-TTS-1, Catapres-TTS-2, Catapres-TTS-3. Find medical information on side effects, drug interactions, dosage, and user ratings and reviews.View full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on April 8, 2010 at 3:09 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Bipolar-disorder Related Drugs, Abilify, Quetiapine ... http://bit.ly/b62GaM #bipolar

2 years ago...

Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate

drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on February 21, 2011 at 10:15 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug

1 year ago...

CDR recommends reimbursement for schizophrenia drug, ABILIFY

news-medical.net — “Bristol-Myers Squibb Canada is pleased to announce that the Common Drug Review (CDR) has recognized the value of ABILIFY® (aripiprazole) for the treatment of schizophrenia and schizoaffective disorders by recommending it be reimbursed by provincial drug plans for patients who have a contraindication to less-expensive antipsychotic agents or who have failed a trial of less expensive antipsychotic agents due to intolerance or lack of response.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on July 22, 2011 at 4:09 pm By:

HIVAIDS_News News-Medical.Net Health News

HIV/AIDS News: CDR recommends reimbursement for schizophrenia drug, ABILIFY: Bristol-Myers Squibb Canada is plea... http://bit.ly/pEram8

10 months ago...

NICE Requests More Data On Aripiprazole For Schizophrenia

medicalnewstoday.com — “In draft guidance , published today (10 September 2010), NICE has asked Bristol-MyersView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 10, 2010 at 6:00 pm By:

mnt_schizophren MNT Schizophrenia Health News

NICE Requests More Data On Aripiprazole For Schizophrenia http://mnt.to/3JBh #schizophrenia

2 years ago...

NICE Recommends Aripiprazole For Schizophrenia In Young People

medicalnewstoday.com — “In final guidance published today, 26 January, NICE has recommended aripiprazole (Abilify, Bristol-Myers Squibb and Otsuka Pharmaceuticals) as an option for the treatment of schizophrenia in peoplView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on January 26, 2011 at 6:05 pm By:

mnt_mentalhealt MNT Mental Health Health News

NICE Recommends Aripiprazole For Schizophrenia In Young People http://mnt.to/3Qts #mentalhealth

1 year ago...

UK's NICE wants more data on BMS schizophrenia drug

health.yahoo.net — “Britain's healthcare cost watchdog said it was unable to recommend use of Bristol-Myers Squibb's schizophrenia drug Abilify in children aged 15 to 17 and has asked for more information on its effectiveness.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on September 10, 2010 at 1:40 am By:

HealthSociety Healthy Society Health News

UK's NICE wants more data on BMS schizophrenia drug http://bit.ly/9QGCG1

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390